← Current compounder rows

Current NDC auxiliary source row compounder:4273

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
73702-146
Product Ndc
73702-146
Product Ndc Digits
73702146
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
Nicotinamide Riboside Chloride 500 mg
Proprietary Name Suffix
[empty]
Nonproprietary Name
Nicotinamide Riboside Chloride 500 mg
Dosage Form Name
INJECTION, SOLUTION
Route Name
INTRAVENOUS
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
Wells Pharma of Houston
Establishment Name
Wells Pharma of Houston
Establishment Fei
[empty]
Substance Name
NICOTINAMIDE RIBOSIDE CHLORIDE
Active Ingredients Info
500 mg/5 mL
History Active Ingredients Raw
NICOTINAMIDE RIBOSIDE CHLORIDE
History Active Ingredients Info Raw
500 mg/5 mL
History Dosage Raw
INJECTION, SOLUTION
Dea Schedule
[empty]
Package Ndc Raw
73702-146-61
Package Ndc
73702-146-61
Package Ndc Digits
7370214661
Package Ndc11
73702014661
Package Description
5 mL in 1 VIAL, GLASS (73702-146-61)
Reporting Period Raw
2025-1
Reporting Period
2025-1
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:4273
Source Row Number
4273
Source Row Hash
e782e4a7fca5b5cd0d9c6412978c2e2a7d8921b159d009a5f7b22087fe6f04bb
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "73702-146",
    "DEASCHEDULE": "",
    "LABELERNAME": "Wells Pharma of Houston",
    "SUBSTANCENAME": "NICOTINAMIDE RIBOSIDE CHLORIDE",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "73702-146-61",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Nicotinamide Riboside Chloride 500 mg",
    "REPORTINGPERIOD": "2025-1",
    "NONPROPRIETARYNAME": "Nicotinamide Riboside Chloride 500 mg",
    "PACKAGEDESCRIPTION": "5 mL in 1 VIAL, GLASS (73702-146-61) ",
    "ACTIVEINGREDIENTSINFO": "500 mg/5 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:4273
Source Row Number
4273
Status Scope
package
Lookup Ndc
73702-146-61
Lookup Ndc Digits
7370214661
Product Ndc
73702-146
Product Ndc Digits
73702146
Package Ndc
73702-146-61
Package Ndc Digits
7370214661
Package Ndc11
73702014661
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2025-1
Reporting Period
2025-1
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
e782e4a7fca5b5cd0d9c6412978c2e2a7d8921b159d009a5f7b22087fe6f04bb
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45